NCT05789316

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS) Protocol

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 55 (actual)
• Sponsor: Washington University School of Medicine · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the effectiveness, feasibility, acceptability, and appropriateness of an ototoxicity screening protocol among head and neck (H\&N) cancer patients followed in survivorship clinic that received cisplatin-based chemoradiation therapy (CRT).

Conditions

• Head and Neck Cancer Survivors
• Cancer of the Head and Neck Surviors

Interventions

Type	Name	Description
OTHER	Ototoxicity Screening Protocol	The ototoxicity screening protocol contains a functional and objective component. The functional component is the Hearing Handicap Inventory for the Elderly - Screening Version (HHIE-S). The objective component will be pure tone audiometry. A 2 kHz tone at 40 dB will play through over-the-ear headphones and subjects will indicate whether they heard it.

Timeline

• Start date: 2023-06-06
• Primary completion: 2025-11-21
• Completion: 2025-11-21
• First posted: 2023-03-29
• Last updated: 2026-01-12

Locations

1 site across 1 country: United States